Russian Heart Failure Journal 2008year Genetic determinancy of inflammation in atherosclerotic damage of cardiac vasculature


To access this material please log in or register

Register Authorize
2008/

Genetic determinancy of inflammation in atherosclerotic damage of cardiac vasculature

Orlova N.V.

Keywords:

DOI:

Urgency. Prevalence of CVD and related disability and mortality warrant continued study of pathogenetic mechanisms for development of this pathology. Aim. Revealing the interrelation between inflammatory indices and severity of coronary atherosclerotic lesions and their dependence on IL-10 and TNF-α gene polymorphism. Materials and methods. 160 patients with IHD were evaluated. Coronary angiography was performed; haptoglobin, С-reactive protein (CRP), α1-antitrypsin, orsomucoid, complement С3 component, ceruloplasmin, TNF-α, INF-γ, I–L4, IL-6, IL-8 and IL-10 levels were measured; and TNF-α and IL-10 gene polymorphism was determined. Results. We revealed an interrelation between coronary artery lesions and severity of inflammation markers and inflammation gene polymorphism. Therefore the inflammatory mechanism of coronary artery lesions may be genetically predefined.
    1.    Lee SC, Pu YB, Thomas GN et al. Tumor necrosis factor alpha gene G-308A polymorphism in the metabolic syndrome. Metabolism. 2000;49 (8):1021–1024.
    2.    Jorde LB, Williams RR. Relation between family history of coronary artery disease and coronary risk variables. Am J Cardiol. 1988;62 (10 Pt 1):708–713.
    3.    Назаров П. Г. Реактанты острой фазы воспаления, 2001
    4.    Arnalich F, Hernanz A, López-Maderuelo D et al. Enhanced acute-phase response and oxidative stress in older adults with type II diabetes. Horm Metab Res. 2000;32 (10):407–412.
    5.    Brasier AR, Li J, Wimbish KA. Tumor necrosis factor activates angiotensinogen gene expression by the Rel A transactivator. Hypertension. 1996;27 (4):1009–1017.
    6.    Keso T, Perola M, Laippala P et al. Polymorphisms within the tumor necrosis factor locus and prevalence of coronary artery disease in middle-aged men. Atherosclerosis. 2001;154 (3):691–697.
    7.    Linton MF, Atkinson JB, Fazio S. Prevention of atherosclerosis in apolipoprotein E-deficent mice by bone marrow transplantation Science. 1995;267 (5200):1034–1037.
    8.    Орлова Н. В. Значение острофазовых белков и иммунологических показателей для дианостики и прогноза инфаркта миокарда. Дисс. к. м. н. 1989.
    9.    Woods A, Brull DJ, Humphries SE, Montgomery HE. Genetics of inflammation and risk of coronary artery disease: the central role of interleukin-6. Eur Heart J. 2000;21 (19):1574–1583.
    10.    Harris TB, Ferrucci L, Tracy RP et al. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med. 1999;106 (5):506–512.
    11.    Sarraf P, Frederich RC, Turner EM et al. Multiple cytokines and acute inflammation raise mouse leptin levels: potential role in inflammatory anorexia. J Exp Med. 1997;185 (1):171–175.
    12.    Wilson AG, Symons JA, McDowell TL et al. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci U S A. 1997;94 (7):3195–3199.
    13.    Momiyama Y, Hirano R, Taniguchi H et al. Effects of interleukin-1 gene polymorphisms on the development of coronary artery disease associated with Chlamydia pneumoniae infection. J Am Coll Cardiol. 2001;38 (3):712–717.
    14.    Ferrari SL, Ahn-Luong L, Gamero Р et al. Two promoter polymorphisms regulating interleukin-6 gene expression are associated with circulating levels of C-reactive protein and markers of bone resorption in postmenopausal women. J Clin Endocrinol Metab. 2003;88 (1):255–259.
    15.    Kiechl S, Lorenz E, Reindl M et al. Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med. 2002;347 (3):185–192.
    16.    Jerrard-Dunne P, Sitzer M, Risley P et al. Interleukin-6 promoter polymorphism modulates the effects of heavy alcohol consumption on early carotid artery atherosclerosis: the Carotid Atherosclerosis Progression Study (CAPS). Stroke. 2003;34 (2):402–407.
    17.    Flex A, Gaetani E, Pola R et al. The -174 G / C polymorphism of the interleukin-6 gene promoter is associated with peripheral artery occlusive disease. Eur J Vasc Endovasc Surg. 2002;24 (3):264–268.
    18.    Nauck M, Winkelmann BR, Hoffmann MM et al. The interleukin-6 G (-174) C promoter polymorphism in the LURIC cohort: no association with plasma interleukin-6, coronary artery disease, and myocardial infarction. J Mol Med. 2002;80 (8):507–513.
    19.    Namiki M, Kawashima S, Yamashita T et al. Intramuscular gene transfer of interleukin-10 cDNA reduces atherosclerosis in apolipoprotein E-knockout mice. Atherosclerosis. 2004;172 (1):21–29.
    20.    Fichtlscherer S, Breuer S, Heeschen C et al. Interleukin-10 serum levels and systemic endothelial vasoreactivity in patients with coronary artery disease. J Am Coll Cardiol. 2004;44 (1):44–49.
    21.    McGlinchey PG, Spence MS, Patterson CC et al. Cytokine gene polymorphisms in ischaemic heart disease: investigation using family-based tests of association. J Mol Med. 2004;82 (11):756–761.
    22.    Herrmann SM, Ricard S, Nicaud V et al. Polymorphisms of the tumour necrosis factor-alpha gene, coronary heart disease and obesity. Eur J Clin Invest. 1998;28 (1):59–66.
    23.    Koch W, Kastrati А, Bottiger С et al. Interleukin-10 and tumor necrosis factor gene polymorphisms and risk of coronary artery disease and myocardial infarction. Atherosclerosis. 2001;159 (1):137–144.
    24.    Francis SE, Camp NJ, Dewberry RM et al. Interleukin-1 receptor antagonist gene polymorphism and coronary artery disease. Circulation. 1999;99 (7):861–866.
    25.    Padovani JC, Pazin-Filho А, Simoes MV et al. Gene polymorphisms in the TNF locus and the risk of myocardial infarction. Thromb Res. 2000;100 (4):263–269.

To access this material please log in or register

Register Authorize
Ru En